Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | KDM6B | O15054 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | GALK1 | P51570 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28782480 | 0.93 | PTPN1 (0.47) | MAOBPTPN1SLC6A2PTPN2KDM6B | |
| SCHEMBL29994094 | 0.88 | SLC6A2 (0.52) | PTPN1SLC6A2PTPN2KDM6BSYNJ2 | |
| SCHEMBL12470949 | 0.88 | SLC6A2 (0.52) | PTPN1SLC6A2PTPN2KDM6BSYNJ2 | |
| SCHEMBL20538999 | 0.87 | SLC5A2 (0.42) | MAOBGAA | |
| SCHEMBL14705921 | 0.86 | PTPN1 (0.52) | MAOBPTPN1PTPN2CYP19A1PRKCA | |
| SCHEMBL1237211 | 0.85 | MAOB (0.65) | MAOBSLC6A2SYNJ2KDM4EABL1 | |
| SCHEMBL1237219 | 0.85 | MAOB (0.65) | MAOBSLC6A2SYNJ2KDM4EABL1 | |
| SCHEMBL29556480 | 0.83 | MAOB (0.51) | MAOBPTPN1CYP19A1PRKCAKDM4E | |
| SCHEMBL8843011 | 0.79 | MAOB (0.70) | MAOBSYNJ2KDM4EABL1ALPL | |
| SCHEMBL3636327 | 0.79 | MAOB (0.70) | MAOBSYNJ2KDM4EABL1ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308166-A1 | ANTIOXIDANT COMPOSITION COMPRISING NOVEL GINSENOSIDE | AMOREPACIFIC CORPORATION (KR) | 2021-10-07 | — | — | US | disclosed |
| US-20210309693-A1 | NOVEL GINSENOSIDE AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME | AMOREPACIFIC CORPORATION (KR) | 2021-10-07 | — | — | US | disclosed |
| US-20200131222-A1 | COMPOSITION FOR ENHANCING EXERCISE ABILITY OR ANTI-FATIGUE COMPRISING NOVEL GINSENOSIDE | AMOREPACIFIC CORPORATION (KR) | 2020-04-30 | — | — | US | disclosed |
| US-20200123194-A1 | COMPOSITION COMPRISING NOVEL GINSENOSIDE | AMOREPACIFIC CORPORATION (KR) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309693-A1 | NOVEL GINSENOSIDE AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME | IL6, RORA, RORC | MAOB 4856/4885PTPN1 817/4885SLC6A2 4590/4885 |
| US-20200131222-A1 | COMPOSITION FOR ENHANCING EXERCISE ABILITY OR ANTI-FATIGUE COMPRISING NOVEL GINSENOSIDE | GYS1, EBP, PYGM | MAOB 4509/4885PTPN1 2541/4885SLC6A2 2854/4885 |
| US-20200123194-A1 | COMPOSITION COMPRISING NOVEL GINSENOSIDE | GPR119, CYP46A1, GYS2 | MAOB 4720/4885PTPN1 419/4885SLC6A2 2454/4885 |
| US-20210308166-A1 | ANTIOXIDANT COMPOSITION COMPRISING NOVEL GINSENOSIDE | TXNRD2, TXNRD3, PRDX3 | MAOB 3023/4885PTPN1 3367/4885SLC6A2 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.